chevron_leftBack
As of 24 June 2026, Bioinfra Life Science, Inc. has a market cap of $2.08M USD, ranking #47176 globally and #2764 in South Korea.
It ranks #4185 in the Healthcare sector, and #886 in the Medical Devices industry.
Key Stats
Market Cap
$2.08MUSD
3.2B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -13% | -17% | -9.1% | -26% | -64% | -64% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
266470
(주)바이오인프라생명과학
ISIN: KR7266470004
Shares Out.:
Shares Outstanding:
27.866M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
100 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.44B
117K%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.21B
58K%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.18B
56K%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.13B
54K%
1.74T KRW
|
-
|
|
KRX: 096530
|
$751.5M
36K%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$526.71M
25K%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
8M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
8M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
8M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
6M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
6M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
5M%
|
22.2
|
chevron_leftBack